Clinical Trial Update: A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir [NA]

View source ↗

Summary

A randomized controlled trial evaluated switching to tenofovir disoproxil fumarate in chronic hepatitis B patients with incomplete response to entecavir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Heptitis B | NA | Status: COMPLETED